#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12584	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2049	610.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1398	1398	C	791	C	737	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	12584	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2049	610.0	0	HET	.	.	.	C226T	.	226	226	C	440	440	C	692	C,T	489,147	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	650.2	0	.	n	.	0	T695C	SNP	695	695	T	1017	1017	C	674	C,T,A	620,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	650.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1960	1960	G	743	G,A	367,330	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	650.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2293	2293	C	779	C,T	721,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	650.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2367	2367	A	755	A	710	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	650.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2919	2919	C	768	C	729	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23156	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	650.2	0	HET	.	.	.	C539T	.	539	539	C	861	861	C	689	C,T	478,157	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1758	folP	855	855	100.0	folP.l15.c4.ctg.1	1625	107.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1015	1017	AGC	168;169;169	A;G;C	157;155;157	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4446	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3483	127.4	1	SNP	p	S91F	1	.	.	271	273	TTC	606	608	TTC	145;144;144	T;T;C	135;134;135	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4446	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3483	127.4	1	SNP	p	G95N	0	.	.	283	285	GGC	618	620	GGC	147;147;148	G;G;C	137;139;137	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4446	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3483	127.4	1	SNP	p	D95G	1	.	.	283	285	GGC	618	620	GGC	147;147;148	G;G;C	137;139;137	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1446	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1470	98.2	1	SNP	p	G45D	0	.	.	133	135	GGC	592	594	GGC	158;159;161	G;G;C	153;151;154	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	668	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1038	63.9	0	.	n	.	0	A197.	DEL	197	197	A	539	539	A	151	A	141	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4396	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2944	148.8	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	145;146;148	G;A;C	131;129;135	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4396	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2944	148.8	1	SNP	p	R87W	0	.	.	259	261	CGT	586	588	CGT	150;150;150	C;G;T	137;136;135	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4396	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2944	148.8	1	SNP	p	R87I	0	.	.	259	261	CGT	586	588	CGT	150;150;150	C;G;T	137;136;135	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4396	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2944	148.8	1	SNP	p	S87R	1	.	.	259	261	CGT	586	588	CGT	150;150;150	C;G;T	137;136;135	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4396	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2944	148.8	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	150;151;150	T;C;C	136;137;135	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3680	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2470	148.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1445	1447	GGC	185;185;182	G;G;C	171;167;165	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1209	1211	GCA	182;188;188	G;C;A	168;172;175	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1212	1214	ATC	188;188;186	A;T;C	172;174;172	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1224	1226	GTG	189;187;187	G;T;G	176;172;176	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1224	1226	GTG	189;187;187	G;T;G	176;172;176	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1728	1730	ACC	162;161;159	A;C;C	146;148;149	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1782	1784	GCG	163;163;161	G;C,T;G	139;127,1;135	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1782	1784	GCG	163;163;161	G;C,T;G	139;127,1;135	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1905	1907	AGC	135;134;133	A;G,A;C	124;123,1;121	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1914	1916	GGC	129;128;127	G;G;C	119;115;114	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3300	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2356	139.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1932	1934	CCG	123;124;122	C,G;C,G;G,A	88,3;94,1;84,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4810	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3076	156.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	192;193;195	C;C;G	170;178;179	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1910	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1671	113.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	512	512	C	134	C	120	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	402	404	GAA	194;195;195	G;A;A	184;182;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	690	692	GAT	189;187;189	G;A;T	179;176;180	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	813	815	TCA	189;186;188	T;C,T;A	177;176,1;179	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	942	944	GTC	167;166;167	G;T;C,T	161;151;158,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	954	956	TCT	173;175;178	T;C;T	165;167;170	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1104	1106	GTG	199;202;197	G,A;T;G	186,1;189;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1272	1274	GCA	196;193;196	G;C;A	181;180;184	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	1	SNP	p	G120K	1	.	.	358	360	AAG	648	650	AAG	176;176;177	A;A;G	166;165;166	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	1	SNP	p	A121D	1	.	.	361	363	GAC	651	653	GAC	177;175;177	G;A;C	167;161;166	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2326	porB1b	1047	1047	99.04	porB1b.l15.c4.ctg.1	1474	156.6	1	SNP	p	D121N	0	.	.	361	363	GAC	651	653	GAC	177;175;177	G;A;C	167;161;166	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9172	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5030	182.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1040	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1104	93.6	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	233;233;235	A;T;G	219;217;217	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
